Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) today announced that Executive Vice President and CFO Jean-Jacques (JJ) ...

Wall Street analysts forecast that Bausch Health (BHC) will report quarterly earnings of $1.21 per share in its upcoming release, pointing to a year-over-year increase of 5.2%. It is anticipated that ...

Is On Investors’ Radar Today Bausch Health Companies (NYSE:BHC) has drawn fresh attention after its recent share move, closing at $5.99, which comes against a month return of about 14% and a past 3 ...

Bausch Health Companies (NYSE: BHC), formerly Valeant Pharmaceuticals, has seen its share price rally more than 50% over the last two months. There were 2 main reasons for this: The company’s share ...

Bausch Health (BHC) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended December 2025. This widely-known consensus outlook ...

Bausch Health Companies Inc. (NYSE:BHC) is one of the most undervalued Canadian stocks to buy according to hedge funds. On ...

Investors in Bausch Health Companies Inc (Symbol: BHC) saw new options begin trading today, for the January 2028 expiration. One of the key inputs that goes into the price an option buyer is willing ...